scorecard

You Searched For "Covaxin covid 19" and got 20 results


Sort By:


Business Insider Latest Story Image
3 mins read

Should you be worried about the potential side-effects of the Covishield vaccine?

Thrombosis with Thrombocytopenia Syndrome (TTS), can lead to dangerously low blood clot and platele…

Business Insider Latest Story Image
2 mins read

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…

PTI   


Business Insider Latest Story Image
1 min read

Germany to recognise Bharat Biotech’s 'Covaxin' from June 1

In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…

Business Insider Latest Story Image
2 mins read

Covishield immune responses against Covid variants higher than Covaxin: Study

The yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found t…

PTI   


Business Insider Latest Story Image
1 min read

DCGI gives nod to Bharat Biotech's Covaxin for 6-12 age group in India

The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event w…

Business Insider Latest Story Image
1 min read

India’s Covaxin effective against Delta Plus variant of COVID-19, reveals ICMR study

Covaxin is developed by Bharat Biotech in collaboration with ICMR and National Institute of Pune…

Business Insider Latest Story Image
3 mins read

Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …

Business Insider Latest Story Image
2 mins read

WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait

The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…

Business Insider Latest Story Image
3 mins read

Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study

The results of an interim study recently published in The Lancet showed that two doses of Covaxi…

PTI   


Business Insider Latest Story Image
3 mins read

India's Covaxin 77.8% effective for COVID-19, says Lancet Report

A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…

Business Insider Latest Story Image
1 min read

After Serum Institute of India, Bharat Biotech says it will reduce the cost of COVAXIN for state governments

Bharat Biotech, the company behind the COVID-19 vaccine COVAXIN, has slashed the price of its vacci…

Business Insider Latest Story Image
2 mins read

Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years

According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…

Business Insider Latest Story Image
2 mins read

Bharat Biotech begins COVAXIN supply to 14 states based on central government's guidance

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

Business Insider Latest Story Image
2 mins read

Fortis Healthcare to roll out Sputnik V COVID-19 vaccine from June 19

Fortis Healthcare on Thursday announced that Sputnik V vaccine against Covid-19 will be available a…

Business Insider Latest Story Image
2 mins read

Mukesh Ambani-owned Reliance Life Sciences' COVID-19 vaccine — here's all we know so far

Indian pharma firm Reliance Life Sciences on Thursday, August 26, reportedly received regulatory ap…

Business Insider Latest Story Image
2 mins read

AstraZeneca’s COVID-19 vaccine controversy explained — from suspension in Europe to India’s stance

The AstraZeneca COVID-19 vaccine is being taken out of circulation by at least a dozen European cou…

Business Insider Latest Story Image
4 mins read

Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1

The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…

Business Insider Latest Story Image
2 mins read

Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD

"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…

PTI   


Business Insider Latest Story Image
1 min read

DCGI approves study on mixing of Covaxin and Covishield COVID-19 doses, say sources

The trial will involve 300 healthy volunteers. "The aim of the study is to assess the feas…

PTI   


Business Insider Latest Story Image
1 min read

India reports 59,118 new COVID-19 cases in last 24 hours, highest single spike since October last year

India reported 59,118 coronavirus cases in the last 24 hours, highest single-day spike since Octobe…